Cargando…
Peripheral venous congestion causes time‐ and dose‐dependent release of endothelin‐1 in humans
Endothelin‐1 (ET‐1) is a pivotal mediator of vasoconstriction and inflammation in congestive states such as heart failure (HF) and chronic kidney disease (CKD). Whether peripheral venous congestion (VC) increases plasma ET‐1 at pressures commonly seen in HF and CKD patients is unknown. We seek to ch...
Autores principales: | Lin, Jeffrey, Chudasama, Neelesh, Hayashi, Yacki, Hawk, Christopher, Ramnauth, Sahadeo D., Wong, Ka Yuk, Harxhi, Ante, Onat, Duygu, Wakabayashi, Michiyori, Uriel, Nir, Jorde, Ulrich P., LeJemtel, Thierry H., Sabbah, Hani N., Demmer, Ryan T., Colombo, Paolo C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371548/ https://www.ncbi.nlm.nih.gov/pubmed/28320895 http://dx.doi.org/10.14814/phy2.13118 |
Ejemplares similares
-
Mitochondrial Pathobiology and Metabolic Remodeling in Progression to Overt Systolic Heart Failure
por: Chaanine, Antoine H., et al.
Publicado: (2020) -
Elevated plasma endothelin‐1 is related to low natriuresis, clinical signs of congestion, and poor outcome in acute heart failure
por: Zymliński, Robert, et al.
Publicado: (2020) -
Endothelin
por: Davenport, Anthony P., et al.
Publicado: (2016) -
Endothelin and Endothelin Antagonists in Chronic Kidney Disease
por: Kohan, Donald E., et al.
Publicado: (2014) -
Endotheliitis, endothelin, and endothelin receptor blockers in COVID-19
por: Sanghavi, Devang K., et al.
Publicado: (2021)